South Korea
· Delayed Price · Currency is KRW Samjin Pharmaceuticals Company Description
Samjin Pharmaceuticals Co., Ltd. manufactures and sells medicine.
It offers medicine in oral, drop, and injecting forms. The company provides over-the-counter medicines, such as Gevorin, an anti-infalammatory pain killer; Trestan, an appetite stimulant; Flaris, an anti-thrombotic agent; and Nutilin, a brain function improvement agent, as well as medicine for treatment of chronic diseases.
It also develops SA001, which is in Phase II clinical trial for the treatment for dry eye syndrome and Sjogren syndrome; SJP1804 medicine that is Phase I clinical trial to treat macular degeneration; and SJP1604, which is in Phase I clinical trial for cancer; SJP1901 and SJP1902 for cancer treatment; SJP 1801 to treat Alzheimer’s and Parkinson’s disease; SJP006, an anti-viral product; and SJP003 for treatment of diabetes.
In addition, the company's preclinical product is SJP1602 for the treatment of cancer. Samjin Pharmaceuticals Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 1968 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 586 |
| CEO | Yong-Joo Choi |
Contact Details
Address: 121 Wausan Ro Seoul, 04054 South Korea | |
| Phone | 82 2 3140 0700 |
| Website | samjinpharm.co.kr |
Stock Details
| Ticker Symbol | 005500 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7005500004 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Yong-Joo Choi | Chairman and Chief Executive Officer |